Association of Hippo Signalling Pathway With Epigenetic Changes in Cancer Cells and Therapeutic Approaches: An Review Publisher Pubmed



Motavalli R^{1, 2, 3} ; Marofi F⁴ ; Nasimi M⁵ ; Yousefi M⁶ ; Khiavi FM^{7, 8}
Source: Anti-Cancer Agents in Medicinal Chemistry Published:2021

Abstract

Hippo signalling pathway that is evolutionarily conserved affects diver’s pathology and physiology processes, including tissue repair, wound healing, tissue size and tissue regeneration. Epigenetic changes are post-translational modifications in DNA proteins and histones. Epigenetic changes including histone acetylation and deacetylation, miRNAs dysregulation, and aberrant DNA methylation, inflammatory genes actives abnormal in Hippo signaling pathway. Using some treatments, including Histone deacetylases (HDACs), herbal composition, siRNAs and long non-Coding RNA (lncRNA) for suppressing cancer cells by targeting Hippo pathways, may open new views in cancer target therapy fields. The aim of this review study is firstly to demonstrate the importance of Hippo signalling and its association with epigenetic changes in cancer and then to demonstrate progress in targeting Hippo signalling in cancer therapy. © 2021 Bentham Science Publishers.